• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝血管瘤:钆塞酸二钠动态 MRI 增强模式评估。

Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.

机构信息

Department of Radiology, Kawasaki Medical School, 577 Matsushima, Kurashiki City, Okayama 701-0192, Japan.

出版信息

AJR Am J Roentgenol. 2011 Apr;196(4):824-30. doi: 10.2214/AJR.10.5113.

DOI:10.2214/AJR.10.5113
PMID:21427331
Abstract

OBJECTIVE

The aim of this retrospective study was to assess the enhancement patterns of hepatic hemangiomas on gadoxetate disodium.

MATERIALS AND METHODS

A total of 22 patients with 32 hepatic hemangiomas (23 typical type and nine high-flow type) in normal liver underwent gadoxetate disodium-enhanced MRI. Contrast-enhanced images were obtained before and after contrast injection, including arterial phase, portal phase, equilibrium phase, and three hepatobiliary phases (10, 15 and 20 minutes). Signal-to-phantom ratios of hemangiomas and the portal vein as well as lesion-to-liver contrast-to-phantom ratios were assessed.

RESULTS

Mean signal-to-phantom ratios of all 32 hemangiomas showed the highest value on the arterial phase and subsequently decreased over time (p = 0.029 to p < 0.001). Mean lesion-to-liver contrast-to-phantom ratios of all 32 hemangiomas showed a positive value during the arterial phase and increasingly negative values at later time points (p = 0.001 to p < 0.001). The enhancement pattern of hemangiomas was equal to that of the portal vein at all time points. There was no significant difference in signal-to-phantom ratio between typical hemangiomas and high-flow hemangiomas at any time point.

CONCLUSION

Most hepatic hemangiomas showed hypointensity relative to surrounding liver parenchyma during the equilibrium phase and the hepatobiliary phase. In addition, hepatic hemangiomas showed a signal intensity matching the portal vein at all phases, a finding we believe may be characteristic for hepatic hemangiomas on gadoxetate disodium-enhanced MR images.

摘要

目的

本回顾性研究旨在评估钆塞酸二钠增强下肝血管瘤的强化模式。

材料和方法

22 例 32 个肝脏血管瘤(23 个典型型和 9 个高流量型)的患者,在正常肝脏进行了钆塞酸二钠增强 MRI 检查。在注射对比剂前后获得对比增强图像,包括动脉期、门静脉期、平衡期和三个肝胆期(10、15 和 20 分钟)。评估血管瘤和门静脉的信号与肝实质比值,以及病灶与肝实质的对比与肝实质比值。

结果

所有 32 个血管瘤的平均信号与肝实质比值在动脉期最高,随后随时间逐渐下降(p = 0.029 至 p < 0.001)。所有 32 个血管瘤的平均病灶与肝实质的对比与肝实质比值在动脉期为正值,随后时间点的比值逐渐为负值(p = 0.001 至 p < 0.001)。血管瘤的强化模式在各个时间点均与门静脉相同。在任何时间点,典型血管瘤和高流量血管瘤的信号与肝实质比值均无显著差异。

结论

在平衡期和肝胆期,大多数肝血管瘤相对于周围肝实质呈低信号。此外,肝血管瘤在各个阶段的信号强度与门静脉匹配,我们认为这可能是钆塞酸二钠增强磁共振图像上肝血管瘤的特征表现。

相似文献

1
Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium.肝血管瘤:钆塞酸二钠动态 MRI 增强模式评估。
AJR Am J Roentgenol. 2011 Apr;196(4):824-30. doi: 10.2214/AJR.10.5113.
2
Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI.肝血管瘤与转移瘤的鉴别:钆塞酸二钠增强 3.0T MRI 表现
AJR Am J Roentgenol. 2010 Oct;195(4):941-6. doi: 10.2214/AJR.09.3730.
3
Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.肝血管瘤:3T MR 成像对比钆贝葡胺与钆塞酸二钠增强模式的差异。
Eur J Radiol. 2012 Oct;81(10):2457-62. doi: 10.1016/j.ejrad.2011.10.014. Epub 2011 Dec 3.
4
Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein.钆塞酸二钠增强肝脏 MRI:肝脏实质和门静脉的剂量依赖性对比动态。
AJR Am J Roentgenol. 2011 Jan;196(1):W18-24. doi: 10.2214/AJR.10.4387.
5
Biologic factors affecting HCC conspicuity in hepatobiliary phase imaging with liver-specific contrast agents.影响肝胆期特异性对比剂增强肝脏 MRI 肝癌显示的生物学因素。
AJR Am J Roentgenol. 2013 Aug;201(2):322-31. doi: 10.2214/AJR.12.9478.
6
Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.MRI 诊断局灶性结节性增生:对比钆贝葡胺与钆塞酸二钠的多中心回顾性研究。
AJR Am J Roentgenol. 2012 Jul;199(1):35-43. doi: 10.2214/AJR.11.7757.
7
Gadoxetate disodium-enhanced hepatobiliary phase MRI of hepatocellular carcinoma: correlation with histological characteristics.钆塞酸二钠增强肝胆期 MRI 对肝细胞癌的诊断:与组织学特征的相关性。
AJR Am J Roentgenol. 2011 Aug;197(2):399-405. doi: 10.2214/AJR.10.5439.
8
Peripheral low intensity sign in hepatic hemangioma: diagnostic pitfall in hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI of the liver.肝脏 Gd-EOB-DTPA 增强 MRI 肝胆期外周低信号影:诊断陷阱肝血管瘤。
J Magn Reson Imaging. 2012 Apr;35(4):852-8. doi: 10.1002/jmri.23514. Epub 2011 Nov 29.
9
Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.钆塞酸二钠增强磁共振成像与增强 CT 对肝血管瘤的影像学特征比较。
World J Gastroenterol. 2012 Nov 21;18(43):6269-76. doi: 10.3748/wjg.v18.i43.6269.
10
Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.钆塞酸二钠增强磁共振成像:鉴别早期强化非肿瘤性病变与富血管性肝细胞癌。
Eur J Radiol. 2011 Aug;79(2):e108-12. doi: 10.1016/j.ejrad.2011.04.041. Epub 2011 May 17.

引用本文的文献

1
Intraindividual crossover comparison of gadobenate dimeglumine-enhanced and gadoxetate disodium-enhanced MRI for characterizing focal liver lesions.钆布醇与钆塞酸二钠增强MRI对肝脏局灶性病变特征的个体内交叉比较。
Eur Radiol Exp. 2025 Feb 18;9(1):23. doi: 10.1186/s41747-025-00551-8.
2
Imaging features and management of focal liver lesions.肝脏局灶性病变的影像学特征与管理
World J Radiol. 2024 Jun 28;16(6):139-167. doi: 10.4329/wjr.v16.i6.139.
3
Differentiating Liver Hemangioma from Metastatic Tumor Using T2-enhanced Spin-echo Imaging with a Time-reversed Gradient-echo Sequence in the Hepatobiliary Phase of Gadoxetic Acid-enhanced MR Imaging.
在钆塞酸增强磁共振成像肝胆期,使用反转时间梯度回波序列的 T2 增强自旋回波成像对肝血管瘤与转移瘤进行鉴别。
Magn Reson Med Sci. 2022 Jul 1;21(3):445-457. doi: 10.2463/mrms.mp.2020-0151. Epub 2021 Apr 20.
4
Imaging of hepatic hemangioma: from A to Z.肝血管瘤的影像学表现:从 A 到 Z。
Abdom Radiol (NY). 2020 Mar;45(3):672-691. doi: 10.1007/s00261-019-02294-8.
5
Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules.磁共振扩散峰度成像与常规扩散加权成像鉴别肝细胞癌与良性肝结节的比较
Contrast Media Mol Imaging. 2019 Jul 17;2019:2030147. doi: 10.1155/2019/2030147. eCollection 2019.
6
Gadoxetic acid-enhanced magnetic resonance imaging: Hepatocellular carcinoma and mimickers.钆塞酸增强磁共振成像:肝细胞癌及类似病变。
Clin Mol Hepatol. 2019 Sep;25(3):223-233. doi: 10.3350/cmh.2018.0107. Epub 2019 Jan 21.
7
Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients.肝硬化患者 Gd-EOB-DPTA 增强 MRI 下不定型肝细胞结节的演变。
Radiol Med. 2018 Jul;123(7):489-497. doi: 10.1007/s11547-018-0873-8. Epub 2018 Mar 15.
8
Liver Masses: What Physicians Need to Know About Ordering and Interpreting Liver Imaging.肝脏肿物:医生在开具和解读肝脏影像检查时需要了解的内容。
Curr Gastroenterol Rep. 2017 Oct 18;19(11):58. doi: 10.1007/s11894-017-0596-3.
9
Transient washout of hepatic hemangiomas: Potential pitfall mimicking malignancy.肝血管瘤的短暂性洗脱:类似恶性肿瘤的潜在陷阱。
Radiol Case Rep. 2016 Apr 6;11(2):62-6. doi: 10.1016/j.radcr.2016.02.010. eCollection 2016 Jun.
10
Imaging findings of mimickers of hepatocellular carcinoma.肝细胞癌的模仿者的影像学表现。
Clin Mol Hepatol. 2015 Dec;21(4):326-43. doi: 10.3350/cmh.2015.21.4.326. Epub 2015 Dec 24.